Josephine Offerhaus posted on LinkedIn
Micreos Initiates P-I/IIa Study Evaluating XZ.700 as the World's First Endolysin Therapy for Atopic Dermatitis
Investigating the potential of endolysin loaded chitosan nanoparticles in the treatment of pneumococcal pneumonia - ScienceDirect
New Gladskin Eczema Cream Is Based on Three Billion Years of Nature's Work
Micreos sidesteps antibiotic resistance, targeting superbugs with $37M for endolysin | 2021-10-04 | BioWorld
Antibiotics | Free Full-Text | Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
Frontiers | Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Micreos (@Micreos) / X
BBC Two - Trust Me, I'm a Doctor, Series 6, Episode 2 - Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics?
So Glad We Found Gladskin Eczema Cream - LimByLim
Pharmaceuticals | Free Full-Text | Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens
Endolysin Science | Gladskin
Gladskin: Revolutionizing Eczema Care & Restoring Skin Health
Viruses | Free Full-Text | The Advantages and Challenges of Using Endolysins in a Clinical Setting
Viruses | Free Full-Text | The Advantages and Challenges of Using Endolysins in a Clinical Setting
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine
UTROLIG Universalsalve 2011
Endolysin Science | Gladskin
Targeted Endolysin Whitepapers | Gladskin
Targeted Endolysin Whitepapers | Gladskin
How to treat eczema: New breakthrough study proves certain products can improve quality of life
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Micreos
Endolysins Vs MRSA
NEW STUDY: Gladskin ingredient Staphefekt™ found to significantly redu
